HK

Hardik Kabra

Active Director Director DIN 10677976
DIN 10677976 First appointment Jun 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Hardik Kabra

Data last updated:

Hardik Kabra is a Director at Curetech Pathology Private Limited (since 2024). Curetech Pathology Private Limited reported revenue of ₹91 Lakh (FY 2025).

DIN 10677976
Primary Designation Director
First Appointment 22 Jun 2024
Oldest Company Age 2 yrs
Largest company Curetech Pathology Private Limited · ₹91 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curetech Pathology Private Limited U86905GJ2024PTC152744
Director22 Jun 20242024₹91 Lakh (FY 2025)Active

Board colleagues of Hardik Kabra

NameDINCompanyDesignation
Vipul Prabhudas Chavda09513251Curetech Pathology Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curetech Pathology Private Limited
Premium access

Shareholding and investment profile for Hardik Kabra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hardik Kabra

Hardik Kabra currently holds 1 directorship: Curetech Pathology Private Limited (Director, since 22 Jun 2024, revenue ₹91 Lakh (FY 2025)).

Hardik Kabra was first appointed on 22 Jun 2024 as Director at Curetech Pathology Private Limited.

The current boards of Hardik Kabra's companies include Vipul Prabhudas Chavda (Curetech Pathology Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available